| Symbol |
Name |
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIRE
|
autoimmune regulator
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP4
|
aquaporin 4
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF18
|
Rho/Rac guanine nucleotide exchange factor (GEF) 18
|
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4
|
|
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZIN2
|
antizyme inhibitor 2
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic
|
|
BCAT2
|
branched chain amino-acid transaminase 2, mitochondrial
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C6ORF25
|
chromosome 6 open reading frame 25
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCNA2
|
cyclin A2
|
|
CCNB3
|
cyclin B3
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300E
|
CD300e molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD300LD
|
CD300 molecule-like family member d
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD6
|
CD6 molecule
|
|
CD69
|
CD69 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CENPA
|
centromere protein A
|
|
CENPT
|
centromere protein T
|
|
CFH
|
complement factor H
|
|
CHRDL2
|
chordin-like 2
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL6A5
|
collagen, type VI, alpha 5
|
|
COL6A6
|
collagen, type VI, alpha 6
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSG
|
cathepsin G
|
|
CTSK
|
cathepsin K
|
|
CTSZ
|
cathepsin Z
|
|
CTXN3
|
cortexin 3
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAAM1
|
dishevelled associated activator of morphogenesis 1
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DEFB126
|
defensin, beta 126
|
|
DNM1
|
dynamin 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPPA2
|
developmental pluripotency associated 2
|
|
DSG1
|
desmoglein 1
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
DYRK4
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FCRL4
|
Fc receptor-like 4
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGG
|
fibrinogen gamma chain
|
|
FLG
|
filaggrin
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
FRMD7
|
FERM domain containing 7
|
|
FTO
|
fat mass and obesity associated
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GDF5
|
growth differentiation factor 5
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GNAS
|
GNAS complex locus
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBB
|
hemoglobin, beta
|
|
HCAR1
|
hydroxycarboxylic acid receptor 1
|
|
HDC
|
histidine decarboxylase
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXA10
|
homeobox A10
|
|
HPS5
|
Hermansky-Pudlak syndrome 5
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL17F
|
interleukin 17F
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL1B
|
interleukin 1, beta
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KIF21A
|
kinesin family member 21A
|
|
KIF4A
|
kinesin family member 4A
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KLC3
|
kinesin light chain 3
|
|
KLK1
|
kallikrein 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LACRT
|
lacritin
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPG
|
lipase, endothelial
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LY96
|
lymphocyte antigen 96
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBP
|
myelin basic protein
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED15
|
mediator complex subunit 15
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFSD8
|
major facilitator superfamily domain containing 8
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR122
|
microRNA 122
|
|
MIR490
|
microRNA 490
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKS1
|
Meckel syndrome, type 1
|
|
MLANA
|
melan-A
|
|
MLPH
|
melanophilin
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPDZ
|
multiple PDZ domain protein
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MT1A
|
metallothionein 1A
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC19
|
mucin 19, oligomeric
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYLK
|
myosin light chain kinase
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist
|
|
NBR1
|
neighbor of BRCA1 gene 1
|
|
NEO1
|
neogenin 1
|
|
NES
|
nestin
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP2
|
neuropilin 2
|
|
NTN4
|
netrin 4
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUP62
|
nucleoporin 62kDa
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
|
P3H1
|
prolyl 3-hydroxylase 1
|
|
PAFAH2
|
platelet-activating factor acetylhydrolase 2, 40kDa
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDHA2
|
pyruvate dehydrogenase (lipoamide) alpha 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PF4
|
platelet factor 4
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIP
|
prolactin-induced protein
|
|
PKP4
|
plakophilin 4
|
|
PLAC1
|
placenta-specific 1
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK4
|
polo-like kinase 4
|
|
PLN
|
phospholamban
|
|
PLS3
|
plastin 3
|
|
POF1B
|
premature ovarian failure, 1B
|
|
PON1
|
paraoxonase 1
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRSS27
|
protease, serine 27
|
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PUM1
|
pumilio RNA-binding family member 1
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP2
|
RAN binding protein 2
|
|
REEP1
|
receptor accessory protein 1
|
|
REEP2
|
receptor accessory protein 2
|
|
RET
|
ret proto-oncogene
|
|
RFX6
|
regulatory factor X, 6
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RNF123
|
ring finger protein 123
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPGRIP1
|
retinitis pigmentosa GTPase regulator interacting protein 1
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RSPH1
|
radial spoke head 1 homolog (Chlamydomonas)
|
|
RTN4R
|
reticulon 4 receptor
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCGB1D2
|
secretoglobin, family 1D, member 2
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
|
|
SLC9B2
|
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPPL2B
|
signal peptide peptidase like 2B
|
|
SPPL3
|
signal peptide peptidase like 3
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
STRA8
|
stimulated by retinoic acid 8
|
|
STX16
|
syntaxin 16
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
TACR1
|
tachykinin receptor 1
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TMEM173
|
transmembrane protein 173
|
|
TMSB10
|
thymosin beta 10
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNS1
|
tensin 1
|
|
TP53
|
tumor protein p53
|
|
TRA
|
T cell receptor alpha locus
|
|
TRB
|
T cell receptor beta locus
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRO
|
trophinin
|
|
TRPC2
|
transient receptor potential cation channel, subfamily C, member 2, pseudogene
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TYK2
|
tyrosine kinase 2
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VSIG1
|
V-set and immunoglobulin domain containing 1
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
|
XAGE1B
|
X antigen family, member 1B
|
|
YBX2
|
Y box binding protein 2
|
|
YIPF5
|
Yip1 domain family, member 5
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZNF382
|
zinc finger protein 382
|
